Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.2 | 20.4 | 0.0 | 3.1 |
| Revenue growth | -98.9% | | -100.0% | |
| Cost of goods sold | 0.5 | 0.0 | 0.0 | 15.8 |
| Gross profit | -0.3 | 20.4 | 0.0 | -12.8 |
| Gross margin | -114.6% | 100.0% | | -413.7% |
| Research and development | 74.3 | 48.0 | 11.4 | |
| General and administrative | 70.4 | 92.7 | 80.7 | 5.1 |
| EBIT | -160.8 | -194.4 | -180.7 | -17.8 |
| EBIT margin | -69009.9% | -953.9% | | -578.7% |
| Pre-tax income | -135.2 | -136.6 | -101.8 | -17.5 |
| Income taxes | -6.2 | -4.0 | -0.3 | 0.0 |
| Tax rate | 4.6% | 2.9% | 0.3% | 0.0% |
| Net income | -152.4 | -167.8 | -169.8 | -24.4 |
| Net margin | -65401.3% | -823.6% | | -790.7% |
| |
| Diluted EPS | ($0.98) | ($1.21) | ($1.83) | |
| Shares outstanding (diluted) | 155.7 | 138.3 | 93.0 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|